Boris Johnson COVID Briefing

The transcript discusses reports of a rare blood clot, CSVT, occurring after AstraZeneca COVID-19 vaccination. While investigations are ongoing, no causal link has been established, and the occurrence is extremely rare. The MHRA advises seeking medical attention for specific symptoms and emphasizes that the vaccine's benefits outweigh the risks. The public is encouraged to report side effects through the Yellow Card scheme.

How many reports of CSVT have been received in relation to the COVID-19 vaccine?

What should individuals do if they experience suspected side effects from the COVID-19 vaccine?